Category: Blog

For many people using weight loss medications, appetite changes are expected. What isn’t expected is what might happen after a glass of wine.

New research suggests that popular GLP-1 receptor agonists — including drugs sold under names like Wegovy and Mounjaro — may alter how the body absorbs alcohol and how intoxication feels.

Why researchers looked at alcohol in the first place

Doctors have long noticed that some patients on GLP-1 medications report drinking less.

These drugs, often prescribed for obesity and type 2 diabetes, work by mimicking hormones that regulate appetite and blood sugar. They also slow gastric emptying, meaning food moves more slowly from the stomach into the small intestine.

Researchers at Virginia Tech’s Fralin Biomedical Research Institute wanted to understand whether that delayed digestion could also change how alcohol enters the bloodstream.

Inside the small but revealing study

The study, published in Scientific Reports, involved 20 adults with obesity. Half had been taking a GLP-1 receptor agonist for at least four weeks. The other half were not using the medication.

Participants fasted overnight. They then ate the same standardized snack before consuming carefully measured alcoholic drinks designed to raise breath alcohol concentration to about 0.08 — the legal driving limit in many regions.

Over the next four hours, researchers measured breath alcohol levels, blood sugar, nausea, cravings, and how intoxicated participants said they felt.

A slower rise in alcohol levels

Here’s where things got interesting.

Participants taking GLP-1 medications showed a slower increase in breath alcohol concentration during the first 10 to 20 minutes. Overall levels remained lower throughout the testing period compared to those not on the medication.

They also reported feeling less intoxicated early on.

Researchers say this likely reflects delayed alcohol absorption. Because GLP-1 drugs slow how quickly the stomach empties, alcohol may take longer to move into the small intestine, where most absorption occurs.

In simple terms, alcohol may hit the bloodstream — and the brain — more gradually.

Could this reduce alcohol cravings?

Some participants taking the medication also reported reduced cravings for alcohol.

Scientists believe the mechanism may go beyond digestion alone. GLP-1 receptor agonists interact with brain pathways linked to reward and impulse control.

That matters because faster-acting substances tend to produce stronger reinforcement in the brain. A slower onset may blunt some of alcohol’s rewarding effects.

However, researchers caution that this was a small preliminary study. It does not prove these medications treat alcohol use disorder, and more research is needed to understand long-term effects.

A potential double-edged sword

Not all experts see the findings as straightforwardly positive.

Some have suggested that if people feel less of an initial “buzz,” they might drink more to compensate. Slower onset does not eliminate alcohol’s risks, and delayed intoxication could create a false sense of control.

Researchers emphasized that questions remain about ideal dosing, duration of use, and how different GLP-1 drugs compare.

What this means for patients

The takeaway isn’t that alcohol becomes harmless while on weight loss drugs.

Instead, the study highlights that weight loss drugs and alcohol may interact in ways people don’t expect. Delayed absorption could change how quickly someone feels intoxicated, but it does not remove alcohol from the body or eliminate potential harm.

As GLP-1 receptor agonists become more widely used, understanding these secondary effects becomes increasingly important.

Researchers say larger trials will be needed to clarify whether these medications meaningfully influence long-term drinking patterns — and whether that effect could be helpful or problematic depending on the individual.

For now, the findings add another layer to how powerful these medications can be. They don’t just affect appetite and blood sugar. They may also change how the body responds to alcohol.

Featured Image Credit: Getty Images

Topics: Ozempic, Mounjaro, Health

Sometimes the scariest news arrives in the most ordinary setting. A quick appointment. A routine scan. A moment you expect to laugh off.

That’s the reality Lexy Thornberry says she’s been living since learning she has cancer at 24.

The former Love Island Australia contestant shared the diagnosis with followers in a series of posts, showing parts of her hospital visits and the emotional whiplash that came with it.

The moment she realized it wasn’t “just a check-up”

In one of her updates, Thornberry described how she initially didn’t believe anything serious was happening. She joked about being put in a robe for an X-ray, saying she thought it was “so dramatic.”

Within days, she said, she was diagnosed with head and neck cancer.

It’s the kind of detail that hits hard because it’s relatable: most people don’t walk into a clinic expecting life-changing news.

What she has shared about the diagnosis so far

Thornberry has kept some medical details private, but reports linked to her public posts describe the diagnosis as a rare form of head and neck cancer, with coverage noting nasopharyngeal carcinoma.

She also emphasized a message that many patients repeat after an unexpected diagnosis: she believes there was nothing she “did wrong” to cause it.

In her posts, she framed it as bad luck rather than a simple cause-and-effect story—something that can be important for readers to hear.

Treatment, hair, and the emotional “before and after”

Thornberry showed moments from treatment prep and hospital time, while also trying to keep pieces of her normal life intact.

One part that stood out to many followers: she talked about her hair being the “healthiest it’s ever been,” while facing the reality that chemotherapy can change that.

It’s not vanity. It’s mourning the little things that symbolize normal life—right before everything changes.

Her relationship update and why her fiancé matters in this story

Alongside her posts, Thornberry has appeared with her fiancé, New Zealand boxer David Nyika, as they navigate the diagnosis together.

She reportedly asked him to keep pursuing his career and not let the diagnosis consume every part of their lives. The message was clear: support doesn’t always look like stopping everything—it can also look like staying steady.

The one request she made to the public

After sharing her diagnosis, Thornberry also asked for space.

She requested privacy while starting treatment, saying she would only share what she feels comfortable sharing for now.

That boundary is worth respecting—especially in a moment when public attention can feel overwhelming.

Why stories like this resonate so widely

Cancer diagnoses in young adults can feel especially shocking because people assume age equals safety. Health authorities often stress that symptoms and risk can vary widely by person, which is why persistent concerns should be taken seriously.

Thornberry’s story is also a reminder of something many people learn the hard way: you don’t always get a warning that “sounds serious” at first.

Featured Image Credit: Instagram/@lexythornberry

Topics: Instagram, Cancer, Health, Love Island